JP2013040189A5 - - Google Patents

Download PDF

Info

Publication number
JP2013040189A5
JP2013040189A5 JP2012225014A JP2012225014A JP2013040189A5 JP 2013040189 A5 JP2013040189 A5 JP 2013040189A5 JP 2012225014 A JP2012225014 A JP 2012225014A JP 2012225014 A JP2012225014 A JP 2012225014A JP 2013040189 A5 JP2013040189 A5 JP 2013040189A5
Authority
JP
Japan
Prior art keywords
chemical
compound selected
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012225014A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013040189A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2012225014A priority Critical patent/JP2013040189A/ja
Priority claimed from JP2012225014A external-priority patent/JP2013040189A/ja
Publication of JP2013040189A publication Critical patent/JP2013040189A/ja
Publication of JP2013040189A5 publication Critical patent/JP2013040189A5/ja
Pending legal-status Critical Current

Links

JP2012225014A 2010-06-11 2012-10-10 薬剤多量体微粒子及びその製造方法 Pending JP2013040189A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012225014A JP2013040189A (ja) 2010-06-11 2012-10-10 薬剤多量体微粒子及びその製造方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010133486 2010-06-11
JP2010133486 2010-06-11
JP2012225014A JP2013040189A (ja) 2010-06-11 2012-10-10 薬剤多量体微粒子及びその製造方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012519401A Division JP5113958B2 (ja) 2010-06-11 2011-06-07 薬剤多量体微粒子及びその製造方法

Publications (2)

Publication Number Publication Date
JP2013040189A JP2013040189A (ja) 2013-02-28
JP2013040189A5 true JP2013040189A5 (enExample) 2014-07-24

Family

ID=45098106

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012519401A Active JP5113958B2 (ja) 2010-06-11 2011-06-07 薬剤多量体微粒子及びその製造方法
JP2012225014A Pending JP2013040189A (ja) 2010-06-11 2012-10-10 薬剤多量体微粒子及びその製造方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2012519401A Active JP5113958B2 (ja) 2010-06-11 2011-06-07 薬剤多量体微粒子及びその製造方法

Country Status (5)

Country Link
US (1) US20130096097A1 (enExample)
EP (1) EP2586463B1 (enExample)
JP (2) JP5113958B2 (enExample)
CN (1) CN103068404B (enExample)
WO (1) WO2011155501A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013188727A2 (en) * 2012-06-15 2013-12-19 The Children's Hospital Of Philadelphia Novel pro- and codrug derivatives for nanoparticle delivery of select anticancer agents formed using rapidly cleavable phenolic ester bridges
WO2020154815A1 (en) 2019-02-01 2020-08-06 Ripple Therapeutics Corporation Crystalline forms of dexamethasone dimers and uses thereof
US12509469B2 (en) 2019-08-07 2025-12-30 Ripple Therapeutics Corporation Compositions and methods for the treatment of pain and dependence disorders
CN117015545A (zh) * 2021-03-12 2023-11-07 国立研究开发法人科学技术振兴机构 Sn-38衍生物、包含该衍生物的纳米粒子、医药及该纳米粒子的制造方法
AU2023390747A1 (en) * 2022-12-09 2025-06-26 Japan Science And Technology Agency Compound, nanoparticles, medicine and method for producing nanoparticles

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473692A (en) 1981-09-04 1984-09-25 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
JP2723200B2 (ja) 1992-09-07 1998-03-09 均 笠井 非線形光学用有機微結晶の製法
DK1017675T3 (da) 1997-02-14 2006-10-16 Bionumerik Pharmaceuticals Inc Stærkt lipofile camptothecinderivater
US6011042A (en) 1997-10-10 2000-01-04 Enzon, Inc. Acyl polymeric derivatives of aromatic hydroxyl-containing compounds
WO2004008101A2 (en) * 2002-07-12 2004-01-22 Biomarin Pharmaceutical Inc. The use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates
US20070041093A1 (en) 2005-08-22 2007-02-22 Stuart Bard Projector screen for use in a lighted room
US7786164B2 (en) * 2005-12-20 2010-08-31 Sonus Pharmaceuticals, Inc. Lipophilic di(anticancer drug) compounds, compositions, and related methods
US8367065B2 (en) 2006-09-15 2013-02-05 Enzon Pharmaceuticals, Inc. Targeted polymeric prodrugs containing multifunctional linkers
KR20090057383A (ko) 2006-09-15 2009-06-05 엔존 파마슈티컬즈, 인코포레이티드 다기능성 링커를 포함하는 표적화된 고분자 전구약물
GB0714223D0 (en) * 2007-07-20 2007-08-29 Fujifilm Mfg Europe Bv Preparation of fine particles
AR069674A1 (es) * 2007-12-13 2010-02-10 Univ Kyushu Nat Univ Corp Nanoparticulas que contienen farmaco
JP5709523B2 (ja) * 2008-11-06 2015-04-30 国立大学法人大阪大学 眼内移行性の高い点眼剤および蛍光イメージング剤ならびにそれらの製造方法
CN101628919B (zh) * 2009-08-20 2011-11-23 浙江大学 喜树碱及其衍生物的自乳化药物前体及其应用

Similar Documents

Publication Publication Date Title
JP2012255926A5 (enExample)
JP2012107057A5 (enExample)
JP2011102971A5 (enExample)
JP2013033060A5 (enExample)
JP2013541578A5 (enExample)
JP2013521563A5 (enExample)
JP2012111758A5 (enExample)
JP2017514877A5 (enExample)
JP2011093937A5 (enExample)
JP2013531034A5 (enExample)
JP2012204203A5 (enExample)
JP2014505137A5 (enExample)
JP2012031285A5 (enExample)
JP2013064178A5 (enExample)
JP2012098270A5 (enExample)
JP2012190699A5 (enExample)
JP2013145868A5 (enExample)
JP2011233516A5 (enExample)
JP2014520786A5 (enExample)
JP2011175463A5 (enExample)
JP2013040189A5 (enExample)
JP2013016377A5 (enExample)
JP2012115928A5 (enExample)
JP2014507463A5 (enExample)
JP2013236836A5 (enExample)